title: Dilated cardiomyopathy induced by anti-tumor necrosis factor.
authors.forename: Andreas
authors.initials: A
authors.lastname: Synetos
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Toutouzas
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Aznaouridis
authors.forename: Stamatios
authors.initials: S
authors.lastname: Lerakis
authors.forename: Chistodoulos
authors.initials: C
authors.lastname: Stefanadis
mesh_terms: D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D002311:Cardiomyopathy, Dilated / Q000139:chemically induced*; D005260:Female; D006801:Humans; D000069285:Infliximab; D008875:Middle Aged; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab